Motivated by an increasing interest in narratives in economics, we investigated the relevance of moral concerns in narratives for policy preferences. Specifically, taking the German debate about genetic engineering of foods (GE) as an example, we conducted a representative online survey in...

The European Research Council (ERC) is the Europe's leading funding body dedicated to funding frontier research, selecting projects based on scientific excellence only, without any predetermined scientific or policy priorities. This report describes how ERC-funded, curiosity-driven research...

The way the projects are selected to establish the portfolio. If the projects are selected based on common research interests (shared component), it is more likely that they would also share common innovation and business objectives and want to collaborate on mutual benefit basis, to...

The way the projects are selected to establish the portfolio. If the projects are selected based on common research interests (shared component), it is more likely that they would also share common innovation and business objectives and want to collaborate on mutual benefit basis, to...

Meritocratic fairness justifies inequality when it stems from performance. Yet performance is influenced by one's genetics. I investigate whether individuals' redistribution preferences are affected by their beliefs about genetics' role in generating performance inequality. In an incentivized...

Motivated by an increasing interest in narratives in economics, we investigated the relevance of moral concerns in narratives for policy preferences. Specifically, taking the German debate about genetic engineering of foods (GE) as an example, we conducted a representative online survey in...

Myriad Genetics is one of the leading biotechnology firms with a specialization in genetic testing, cancer research and precision medicine. Myriad has filed its first patent application in 1995 and now developed a patent portfolio of more than a thousand patent applications. It is almost 10...

The underrepresentation of minority populations in human genomics research has raised growing concerns regarding distributive justice in translating biomedical innovations into human health across populations. We assess how public funding policy helps address the missing diversity in the context...

We empirically assess the potential financial impact of future gene therapies on the US economy. After identifying 109 late-stage gene therapy clinical trials currently underway, we estimate the number of new and existing patients with corresponding diseases to be treated by these gene...

Feed importers in some EU member states face constraints on imports of genetically modified (GM) soy, a practice that may compromise the interests of EU livestock farmers. Using the cases of Sweden and Austria, we analyzed price transmission in the soy supply chain originating from Brazil,...

The study explains in particular the different forms of legal protection required by international IPR agreements, including the system of plant breeders' rights in the 1978 and 1991 UPOV Acts, the choice between patent and sui generis protection created by article 27.3(b) of the TRIPs Agreement...

The extensive adoption of genetically engineered (GE) varieties in U.S. agriculture has dramatically changed the patterns of pesticide use. How this process ultimately affects environmental risk remains an open question. Previous studies have typically relied on aggregate trends to infer the...

"This book makes the case for an urgent move away from industrial agriculture towards regenerative farming and the promotion of plant-based diets. How we produce, distribute and consume food are critical issues for the health and well-being of humans, animals and the environment. In order to...

In the approaching era of genomic medicine, the underrepresentation of minority populations in human genetics and genomics research has raised growing concerns regarding the distributive justice in the translation of biomedical innovations into human health across populations. Quantitative...

The proliferation of direct-to-consumer (DTC) genetic testing poses new regulatory challenges as genetic testing and information, once within the exclusive domain of medical institutions, has migrated into the private commercial sector. The FDA’s traditional “protective” medical device...

This report updates the 2006 analysis in line with the present requirements of BIS.Techniques used in patent landscaping have also evolved since the first report so the analysis in this project is specifically based around the country of residence of patent applicants.This gives a better...

In 2003, the idea of community benefit-sharing in the context of genetic research became an international norm in UNESCO’s International Declaration on Human Genetic Data. Taiwan’s Human Biobank Management Act, newly enacted in 2010, has transferred this ethical norm into national law....

In the approaching era of genomic medicine, the underrepresentation of minority populations in human genetics and genomics research has raised growing concerns regarding the distributive justice in the translation of biomedical innovations into human health across populations. Quantitative...

The unavailability of potential stem cell donors poses a critical challenge for donor registries worldwide. This study investigates the impact of initiatives of a stem cell donor registry to enhance donors' availability for confirmatory typing. Initiatives ask donors to provide a sample for...

This study reports on a survey of Millennials in the United States regarding GMO foods. Potential benefits of GMO food crops include improving agricultural productivity, such as insect resistant and drought resistant crops, and alleviating world hunger, particularly in developing countries....

On the one hand, gene editing is a process of modifying the existing genetic material of an organism. On the other hand, genetic modification involves the introduction of genetic material from another organism. Gene-editing technology is a powerful tool that can boost sustainable farming, fight...

I demonstrate that to achieve dynamic efficiency, the optimal share of total surplus that a social payer should transfer to an innovating industry for a current asset depends on the marginal product of investment and the share of profits invested by the industry on the current asset and not on...